Basilea Pharmaceutica Ag Stock Market Value
| BPMUF Stock | USD 52.83 0.00 0.00% |
| Symbol | Basilea |
Basilea Pharmaceutica 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Basilea Pharmaceutica's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Basilea Pharmaceutica.
| 10/31/2024 |
| 11/30/2024 |
If you would invest 0.00 in Basilea Pharmaceutica on October 31, 2024 and sell it all today you would earn a total of 0.00 from holding Basilea Pharmaceutica AG or generate 0.0% return on investment in Basilea Pharmaceutica over 30 days. Basilea Pharmaceutica is related to or competes with Reviva Pharmaceuticals, Protalix Biotherapeutics, Eyepoint Pharmaceuticals, Sellas Life, ProQR Therapeutics, Alnylam Pharmaceuticals, and Wave Life. Basilea Pharmaceutica AG, a commercial stage biopharmaceutical company, focuses on the development of products that addr... More
Basilea Pharmaceutica Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Basilea Pharmaceutica's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Basilea Pharmaceutica AG upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.24) | |||
| Maximum Drawdown | 3.06 |
Basilea Pharmaceutica Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Basilea Pharmaceutica's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Basilea Pharmaceutica's standard deviation. In reality, there are many statistical measures that can use Basilea Pharmaceutica historical prices to predict the future Basilea Pharmaceutica's volatility.| Risk Adjusted Performance | 0.0838 | |||
| Jensen Alpha | 0.033 | |||
| Total Risk Alpha | (0.03) | |||
| Treynor Ratio | 1.36 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Basilea Pharmaceutica's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Basilea Pharmaceutica Backtested Returns
At this point, Basilea Pharmaceutica is very steady. Basilea Pharmaceutica secures Sharpe Ratio (or Efficiency) of 0.13, which signifies that the company had a 0.13% return per unit of risk over the last 3 months. We have found seventeen technical indicators for Basilea Pharmaceutica AG, which you can use to evaluate the volatility of the firm. Please confirm Basilea Pharmaceutica's Mean Deviation of 0.0914, standard deviation of 0.377, and Risk Adjusted Performance of 0.0838 to double-check if the risk estimate we provide is consistent with the expected return of 0.0486%. Basilea Pharmaceutica has a performance score of 9 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.0268, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Basilea Pharmaceutica's returns are expected to increase less than the market. However, during the bear market, the loss of holding Basilea Pharmaceutica is expected to be smaller as well. Basilea Pharmaceutica right now shows a risk of 0.39%. Please confirm Basilea Pharmaceutica information ratio and rate of daily change , to decide if Basilea Pharmaceutica will be following its price patterns.
Auto-correlation | 1.00 |
Perfect predictability
Basilea Pharmaceutica AG has perfect predictability. Overlapping area represents the amount of predictability between Basilea Pharmaceutica time series from 31st of October 2024 to 15th of November 2024 and 15th of November 2024 to 30th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Basilea Pharmaceutica price movement. The serial correlation of 1.0 indicates that 100.0% of current Basilea Pharmaceutica price fluctuation can be explain by its past prices.
| Correlation Coefficient | 1.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Basilea Pharmaceutica lagged returns against current returns
Autocorrelation, which is Basilea Pharmaceutica pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Basilea Pharmaceutica's pink sheet expected returns. We can calculate the autocorrelation of Basilea Pharmaceutica returns to help us make a trade decision. For example, suppose you find that Basilea Pharmaceutica has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Basilea Pharmaceutica regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Basilea Pharmaceutica pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Basilea Pharmaceutica pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Basilea Pharmaceutica pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Basilea Pharmaceutica Lagged Returns
When evaluating Basilea Pharmaceutica's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Basilea Pharmaceutica pink sheet have on its future price. Basilea Pharmaceutica autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Basilea Pharmaceutica autocorrelation shows the relationship between Basilea Pharmaceutica pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Basilea Pharmaceutica AG.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in Basilea Pink Sheet
Basilea Pharmaceutica financial ratios help investors to determine whether Basilea Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Basilea with respect to the benefits of owning Basilea Pharmaceutica security.